AVITA Medical, Inc.
$5
▼
-1.59%
2026-04-21 09:04:01
avitamedical.com
NCM: RCEL
Explore AVITA Medical, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$157.45 M
Current Price
$5
52W High / Low
$10.29 / $3.22
Stock P/E
—
Book Value
$-0.55
Dividend Yield
—
ROCE
676.75%
ROE
799.72%
Face Value
—
EPS
$-1.74
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
226
Beta
1.89
Debt / Equity
-2.77
Current Ratio
0.57
Quick Ratio
0.46
Forward P/E
-24.71
Price / Sales
2.14
Enterprise Value
$181.33 M
EV / EBITDA
-4.51
EV / Revenue
2.53
Rating
Strong Buy
Target Price
$8.58
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Valuation is not stretched on P/E basis.
Cons
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Bio-Rad Laboratories, Inc. | $302.22 | 10.88 | $8.04 B | — | 2.17% | 10.84% | $343.12 / $211.43 | $276.16 |
| 2. | Sight Sciences, Inc. | $4.36 | — | $220.88 M | — | -35.58% | -50.74% | $9.24 / $2.4 | $1.2 |
| 3. | Picard Medical, Inc. | $0.9 | — | $69.69 M | — | -344.07% | 270.74% | $13.68 / $0.9 | $0.05 |
| 4. | INVO Fertility, Inc. | $2.28 | — | $3.39 M | — | -26.69% | -133.37% | $384 / $1.92 | $-22.34 |
| 5. | Inspira Technologies Oxy B.H.N. Ltd. | $0.59 | — | $21.71 M | — | -541.24% | -3.98% | $1.65 / $0.34 | $0.07 |
| 6. | ENvue Medical, Inc. | $1.51 | — | $5.59 M | — | -394.93% | -30.51% | $75.48 / $0.99 | $42 |
| 7. | iTonic Holdings Ltd. | $0.32 | — | $5.41 M | — | -59.82% | -71.25% | $32 / $0.25 | $0.36 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 17.61 M | 17.06 M | 18.42 M | 18.51 M | 18.41 M |
| Operating Profit | -10.41 M | -9.15 M | -11.15 M | -11.83 M | -9.96 M |
| Net Profit | -11.62 M | -13.19 M | -9.92 M | -13.86 M | -11.59 M |
| EPS in Rs | -0.38 | -0.43 | -0.32 | -0.45 | -0.38 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 71.61 M | 64.25 M | 50.14 M | 34.42 M |
| Operating Profit | -42.53 M | -56.59 M | -42.66 M | -27.5 M |
| Net Profit | -48.59 M | -61.84 M | -35.38 M | -26.66 M |
| EPS in Rs | -1.59 | -2.02 | -1.16 | -0.87 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 56.39 M | 79.71 M | 111.64 M | 98.26 M |
| Total Liabilities | 73.04 M | 75.21 M | 62.58 M | 13.52 M |
| Equity | -16.65 M | 4.5 M | 49.06 M | 84.74 M |
| Current Assets | 35.49 M | 57 M | 104.01 M | 87.46 M |
| Current Liabilities | 62.68 M | 20.16 M | 13.2 M | 10.69 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -31.2 M | -48.94 M | -38.01 M | -19.09 M |
| Investing CF | 12.45 M | 37.36 M | 1.61 M | -19.33 M |
| Financing CF | 14.94 M | 3.51 M | 40.37 M | 0.9 M |
| Free CF | -32.93 M | -58.27 M | -39.46 M | -19.61 M |
| Capex | -1.74 M | -9.33 M | -1.45 M | -0.53 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 28.14% | 45.68% | — | — |
| Earnings Growth % | -74.8% | -32.69% | — | — |
| Profit Margin % | -96.26% | -70.56% | -77.47% | — |
| Operating Margin % | -88.08% | -85.07% | -79.91% | — |
| Gross Margin % | 85.85% | 84.48% | 82.45% | — |
| EBITDA Margin % | -86.07% | -66.89% | -75.67% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.